Intravitreal injections play a critical role in daily ophthalmic practice. The overall risk of
endophthalmitis and retinal detachment appears to be low and most of the commonly used …

Background: Intravitreal injection (IVI) with administration of various pharmacological agents
is a mainstay of treatment in ophthalmology for endopthalmitis, viral retinitis, age-related …

Objective: To compare the efficacy and safety of 1-mg and 4-mg doses of preservative-free
intravitreal triamcinolone with standard care (grid photocoagulation in eyes without dense …

Objective: To compare the efficacy and safety of 1-mg and 4-mg doses of preservative-free
intravitreal triamcinolone with observation for eyes with vision loss associated with macular …

OBJECTIVE: To evaluate the efficacy and safety of 1-mg and 4-mg doses of preservative-
free intravitreal triamcinolone in comparison with focal/grid photocoagulation for the …

Intravitreal injections have become the most commonly performed intraocular treatments
worldwide. Because intravitreal injections may induce severe adverse events, such as …

Background: Intravitreal ranibizumab and pegaptanib are registered for neovascular age-
related macular degeneration. No formal safety study has been conducted for intravitreal …

Our study aimed to comparatively evaluate Micro–Flow Imaging (MFI) and the recently
introduced technique of resonant mass measurement (Archimedes, RMM) as orthogonal …

Purpose To describe a series of previously normotensive eyes experiencing sustained
elevated intraocular pressure (IOP) associated with long-term intravitreal antivascular …

Purpose: To present the finding of tiny silicone oil droplets in 15 eyes of 15 patients after
intravitreal injections of an anti–vascular endothelial growth factor agent or triamcinolone …